16. Green, S., and Weiss, G. R. Southwest Oncology Group standard
response criteria, endpoint definitions and toxicity criteria. Invest. New
Drugs, 10: 239 –253, 1992.
17. McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G.,
Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., and Clift RA.
Veno-occlusive disease of the liver and multiorgan failure after bone
marrow transplantation: a cohort study of 355 patients. Ann. Int. Med.,
118: 255, 1993.
18. Feun, L. G., Wallace, S., Stewart, D. J., Chuang, V. P., Yung,
W. K., Leavens, M. E., Burgess, M. A., Savaraj, N., Benjamin, R. S.,
Young, S. E., Tang, R. A., Handel, S., Mavligit, G., and Fields, W. S.
Intracarotid infusion of cis-diamminedichloroplatinum in the treatment
of recurrent malignant brain tumors. Cancer (Phila.), 54: 794 –799,
1984.
19. Verschraegen, C., Conrad, C. A., and Hong, W. K. Subacute en-cephalopathic toxicity of cisplatin. Lung Cancer, 13: 305–309, 1995.
20. Phillips, G. L., Fay, J. W., Herzig, G. P., Herzig, R. H., Weiner,
R. S., Wolff, S. N., Lazarus, H. M., Karanes, C., Ross, W. E., and
Kramer, B. S. Intensive 1,3-bis(2-chloroehtyl)-1-nitrosourea (BCNU),
NSC #4366650 and cryopreserved autologous marrow transplantation
for refractory cancer. Cancer (Phila.), 52: 1792–1802, 1983.
21. Takvorian, T., Parker, L. M., Hochberg, F. H., and Canellos, G. P.
Autologous bone-marrow transplantation: host effects of high-dose
BCNU. J. Clin. Oncol., 1: 610 – 620, 1983.
22. Burger, P. C., Kamenar, E., Schold, C., Fay, J. W., Phillips, G. L.,
and Herzig, G. P. Encephalomyelopathy following high-dose BCNU
therapy. Cancer (Phila.), 48: 1318 –1327, 1981.
23. Stemmer, S. M., Stears, J. C., Burton, B. S., Jones, R. B., and
Simon, J. H. White matter changes in patients with breast cancer treated
with high-dose chemotherapy and autologous bone marrow support.
Am. J. Neuroradiol., 15: 1267–1273, 1994.
24. Brown, M. S., Stemmer, S. M., Simon, J. H., Stears, J. C., Jones,
R. B., Cagnoni, P. J., and Sheeder, J. L. White mattter disease induced
by high-dose chemotherapy: longitudinal study with MR imaging and
proton spectroscopy. Am. J. Neuroradiol., 19: 217–221, 1998.
25. Webster, L. K., Crinis, N. A., Morton, C. G., and Millward, M. J.
Plasma alcohol concentrations in patients following paclitaxel infusion.
Cancer Chemother. Pharmacol., 37: 499 –501, 1996.
26. Smith, G. D., Shaw, L. J., Maini, P. K., Ward, R. J., Peters, T. J.,
and Murray, J. D. Mathematical model of ethanol metabolism in normal
subjects and chronic alcohol misusers. Alcohol. Alcohol., 28: 25–32,
1993.
27. Habazettl, H., Volmar, B., Rohrich, F., Conzen, P., Doenicke, A.,
and Baethmann, A. Anesthesiologic efficacy of propanidid as liposome
dispersion. An experimental study in rats. Anaesthesis, 41: 448 – 456,
1992.
28. Toung, T. J., Bunke, F. J., Grayson, R. F., Kontos, G. J., Fraser,
C. D., Baumgartner, W. A., Reitz, B. A., and Traytsman, R. J. Effects of
cyclosporine on cerebral blood flow and metabolism in dogs. Transplantation (Baltimore), 53: 1082–1088, 1992.
